Pictet Asset Management (Switzerland)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$176K	Hold	16,495	–	–	﹤0.01%	1760
2023 Q1	$174K	Hold	16,495	–	–	﹤0.01%	1772
2022 Q4	$204K	Buy	16,495 +4,695	+40%	+$53.3K	﹤0.01%	1726
2022 Q3	$122K	Sell	11,800 -305,379	-96%	-$3.46M	﹤0.01%	1455
2022 Q2	$3.66M	Sell	317,179 -670,539	-68%	-$7.9M	0.01%	829
2022 Q1	$12.4M	Sell	987,718 -13,122	-1%	-$150K	0.01%	596
2021 Q4	$11.7M	Sell	1,000,840 -32,847	-3%	-$403K	0.01%	633
2021 Q3	$13.5M	Buy	+1,033,687	New	+$13.4M	0.01%	608

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s IRWD Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2023 at 16,495 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

Pictet Asset Management (Switzerland) first reported a position in IRWD in Q3 2021 and has held it in 8 quarters since. The position peaked at $13.5M in Q3 2021. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

Pictet Asset Management (Switzerland) held 16,495 shares of Ironwood Pharmaceuticals worth $176K as of Q2 2023.
Pictet Asset Management (Switzerland) left its Ironwood Pharmaceuticals share count unchanged in Q2 2023.
Ironwood Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1760 holding.
Pictet Asset Management (Switzerland) first reported a position in Ironwood Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Ironwood Pharmaceuticals position peaked at $13.5M in Q3 2021.
252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.